v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss from continuing operations $ (3,315,003) $ (3,392,305)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 224,686 309,152
Depreciation and amortization of intangible assets 28,376 46,136
Amortization of right of use assets 45,028 93,174
Change in fair value of earnout liabilities (152,049) 29,630
Inventory write-down 235,601 (0)
Changes in operating assets and liabilities:    
Accounts receivable 16,954 26,155
Inventory 120,759 222,210
Prepaid expenses 217,249 321,096
Accounts payable 544,883 258,791
Accrued expenses and other liabilities 199,480 592,530
Contingent liabilities 1,174,155 0
Lease liability (49,291) (95,712)
Net cash used in operating activities (709,172) (1,589,143)
Cash flows from investing activities    
Cash paid for Elevai Acquisition transaction costs 0 (150,000)
Cash paid for offering costs 0 (15,000)
Net cash used in investing activities 0 (165,000)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock, net of costs 190,001 3,397,476
Proceeds from short-term borrowings 50,000 0
Repayment of loans (202,098) (249,273)
Net cash provided by financing activities 37,903 3,148,203
Net (decrease) increase in cash and cash equivalents (671,269) 1,394,060
Cash and cash equivalents - beginning of period 706,740 157,139
Cash and cash equivalents - end of period 35,471 1,551,199
Supplemental cash flow information:    
Interest paid 5,603 7,554
Income taxes paid 0 0
Non-cash investing and financing activities:    
Insurance premium financing agreements 23,457 24,787
Fair value of shares issued in Elevai Acquisition 67,742 660,805
Consideration payable 0 67,742
Earnout liabilities in Elevai Acquisition $ 0 $ 301,633